Micromet, Inc. Reports First Quarter 2008 Financi...(cacy in subsequent clinical trials the r...),Health

Date:5/8/2008

cacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2007, filed with the SEC on March 14, 2008, as well as other filings by the company with the SEC.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Micromet, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except par value)

March 31, December 31,

2008 2007

Assets

Current assets:

Cash and cash equivalents $27,653 $27,066

Accounts receivable 1,734 4,689

Prepaid expenses and other current assets 1,658 2,579

Total current ass
'/>"/>

SOURCE Micromet, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Labopharm Reports Results for First Quarter Fiscal 2008
2. Caliper Life Sciences Reports First Quarter 2008 Results
3. US Oncology Reports First Quarter 2008 Results
4. The Ensign Group, Inc. Reports First Quarter 2008 Earnings
5. Conseco Reports First Quarter Results
6. MedCath Corporation Reports Second Quarter Earnings
7. VENTAS REPORTS FIRST QUARTER NORMALIZED FFO OF $92.4 MILLION AND FAD OF $87.8 MILLION
8. HealthSouth Reports Results for First Quarter Ended March 31, 2008
9. STAAR Surgical Reports Solid First Quarter Progress
10. Claimsnet.com Reports First Quarter 2008 Results
11. HCA Reports First Quarter 2008 Results